PT. Millennium Pharmacon International TBK (SDPC) - Financial and Strategic SWOT Analysis Review

Document Sample
PT. Millennium Pharmacon International TBK (SDPC) - Financial and Strategic SWOT Analysis Review Powered By Docstoc
					            PT. Millennium Pharmacon International TBK (SDPC) - Financial and
                             Strategic SWOT Analysis Review
        Reference Code: GDPH189487FSA                                                                                         Publication Date: SEP 2012

          Floor 9, Panin Bank              Center,    Jl.
                                                             Phone              +62 21 72788907                 Revenue          973,210.72 (million IDR)
          Jenderal Sudirman
          Senayan, Jakarta                                   Fax                +62 21 7228090                  Net Profit       4,001.51 (million IDR)
                                                                                www.mpi-
          10270                                              Website                                            Employees        839
                                                                                indonesia.co.id
                                                                                SDPC [Indonesia Stock                            Pharmaceuticals           &
          Indonesia                                          Exchange                                           Industry
                                                                                Exchange]                                        Healthcare

       Company Overview
       PT. Millennium Pharmacon International TBK ( MPI), formerly, N.V. Perusahaan Dagang Soedarpo Corporation is a
       pharmaceutical distribution company. It carries out the distribution and trading of diagnostics products, pharmaceutical products,
       and food supplements. The company's distribution network comprises 29 branches located in Bali, Sumatera, Java, Sulawesi and
       Kalimantan, five sub-distributors, three central warehouses and 15 sales stations. The products of the company are distributed to
       drug stores, retail shops, pharmacy, hospitals, and supermarket. It is a 55% owned subsidiary of Pharmaniaga Berhad
       (Pharmaniaga) located in Shah Alam, Malaysia.
       Key Executives                                                                SWOT Analysis
                      Name                                  Title                     PT. Millennium Pharmacon International TBK, SWOT
         Ishak Bin Sulaiman                  President Director                       Analysis

         Ahmad Abu Bakar                     Director                                 Strengths                              Weaknesses

         Zulhazri Razali                     Director                                                                        Business Concentration:
                                                                                      Wide Distribution Network
         Ernie A. Hilal                      Secretary                                                                       Indonesia
        Source: Annual Report, Company Website, Primary and Secondary                 Consistent Increase in Revenue
                                                                                                                             Increasing Operating Expenses
        Research, GlobalData

       Share Data
                                                                                      Opportunities                          Threats
         PT. Millennium Pharmacon International TBK
        Share Price (IDR) as on 10-Sep-                                    84         Strategic Agreements and               Government Regulations
        2012                                                                          Collaborations
                                                                                                                             Competitive Pressures
        EPS (IDR)                                                        5.50         Global Pharmaceutical Market
        Market Cap (million IDR)                                      61,880
        Enterprise Value (million IDR)                              149,753          Source: Annual Report, Company Website, Primary and Secondary Research,
                                                                                     GlobalData
        Shares Outstanding (million)                                     728
       Source: Annual Report, Company Website, Primary and Secondary
       Research, GlobalData

       Financial Performance




       Source: Annual Report, Company Website, Primary and Secondary
       Research, GlobalData




PT. Millennium Pharmacon International TBK (SDPC) - Financial                                                                 Reference Code: GDPH189487FSA
and Strategic SWOT Analysis Review
Source : www.globalcompanyintelligence.com                                                                                                                     Page 1
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Table of Contents
       Table of Contents ............................................................................................................................................................................... 2
          List of Tables .................................................................................................................................................................................. 3
          List of Figures ................................................................................................................................................................................. 3
       Section 1 - About the Company.......................................................................................................................................................... 4
       PT. Millennium Pharmacon International TBK - Key Facts ................................................................................................................. 4
       PT. Millennium Pharmacon International TBK - Key Employees ........................................................................................................ 5
       PT. Millennium Pharmacon International TBK - Major Products and Services ................................................................................... 6
       PT. Millennium Pharmacon International TBK - History ..................................................................................................................... 7
       PT. Millennium Pharmacon International TBK - Company Statement ................................................................................................ 8
       PT. Millennium Pharmacon International TBK - Locations And Subsidiaries...................................................................................... 9
          Head Office ..................................................................................................................................................................................... 9
          Other Locations & Subsidiaries ....................................................................................................................................................... 9
       Section 2 – Company Analysis ......................................................................................................................................................... 11
       PT. Millennium Pharmacon International TBK - Business Description ............................................................................................. 11
       PT. Millennium Pharmacon International TBK - SWOT Analysis...................................................................................................... 12
          SWOT Analysis - Overview........................................................................................................................................................... 12
          PT. Millennium Pharmacon International TBK - Strengths ............................................................................................................ 12
             Strength - Wide Distribution Network ........................................................................................................................................ 12
             Strength - Consistent Increase in Revenue ............................................................................................................................... 12
          PT. Millennium Pharmacon International TBK - Weaknesses....................................................................................................... 12
             Weakness - Business Concentration: Indonesia ....................................................................................................................... 12
             Weakness - Increasing Operating Expenses ............................................................................................................................ 12
          PT. Millennium Pharmacon International TBK - Opportunities ...................................................................................................... 13
             Opportunity - Strategic Agreements and Collaborations ........................................................................................................... 13
             Opportunity - Global Pharmaceutical Market............................................................................................................................. 13
             Opportunity - Changing Demographics ..................................................................................................................................... 13
          PT. Millennium Pharmacon International TBK - Threats ............................................................................................................... 13
             Threat - Government Regulations ............................................................................................................................................. 13
             Threat - Competitive Pressures ................................................................................................................................................. 14
             Threat - Product Liability Claims ............................................................................................................................................... 14
       PT. Millennium Pharmacon International TBK - Key Competitors .................................................................................................... 15
       Section 3 – Company Financial Ratios .............................................................
				
DOCUMENT INFO
Description: PT. Millennium Pharmacon International TBK ( MPI), formerly, N.V. Perusahaan Dagang Soedarpo Corporation is a pharmaceutical distribution company. It carries out the distribution and trading of diagnostics products, pharmaceutical products, and food supplements. The company's distribution network comprises 29 branches located in Bali, Sumatera, Java, Sulawesi and Kalimantan, five sub-distributors, three central warehouses and 15 sales stations. The products of the company are distributed to drug stores, retail shops, pharmacy, hospitals, and supermarket. It is a 55% owned subsidiary of Pharmaniaga Berhad (Pharmaniaga) located in Shah Alam, Malaysia. MPI is headquartered in Jakarta, Indonesia.
BUY THIS DOCUMENT NOW PRICE: $125 100% MONEY BACK GUARANTEED
PARTNER GlobalData
GlobalData is an industry analysis specialist, providing business information products and services. GlobalData’s highly qualified team of analysts, researchers, and solution consultants use proprietary data sources, tools and techniques to gather, analyze and represent the latest and the most reliable information essential for a business to sustain a competitive edge. GlobalData is a UK-based company with presence across North America, Europe and Asia Pacific and has a broad product offering that ranges from interactive databases, reports and custom solutions. It is a comprehensive source of insights and analysis with coverage across the oil & gas, power, alternative energy, nuclear power, petrochemicals, medical equipment and healthcare industries. GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries. Sectors and Geographies Covered GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. Research Methodology With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries.